Cogent Receivables Turnover from 2010 to 2025

COGT Stock  USD 9.62  0.32  3.44%   
Cogent Biosciences Receivables Turnover yearly trend continues to be comparatively stable with very little volatility. Receivables Turnover will likely drop to 7.06 in 2025. From the period from 2010 to 2025, Cogent Biosciences Receivables Turnover quarterly data regression had r-value of (0.01) and coefficient of variation of  17.32. View All Fundamentals
 
Receivables Turnover  
First Reported
2010-12-31
Previous Quarter
10.12
Current Value
7.06
Quarterly Volatility
1.70048355
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cogent Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cogent Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.7 M, Interest Expense of 4.8 M or Selling General Administrative of 41.5 M, as well as many indicators such as Price To Sales Ratio of 12.32, Dividend Yield of 0.0 or PTB Ratio of 1.23. Cogent financial statements analysis is a perfect complement when working with Cogent Biosciences Valuation or Volatility modules.
  
Check out the analysis of Cogent Biosciences Correlation against competitors.
For more information on how to buy Cogent Stock please use our How to Invest in Cogent Biosciences guide.

Latest Cogent Biosciences' Receivables Turnover Growth Pattern

Below is the plot of the Receivables Turnover of Cogent Biosciences over the last few years. It is Cogent Biosciences' Receivables Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cogent Biosciences' overall financial position and show how it may be relating to other accounts over time.
Receivables Turnover10 Years Trend
Very volatile
   Receivables Turnover   
       Timeline  

Cogent Receivables Turnover Regression Statistics

Arithmetic Mean9.82
Geometric Mean9.65
Coefficient Of Variation17.32
Mean Deviation1.21
Median10.16
Standard Deviation1.70
Sample Variance2.89
Range5.4138
R-Value(0.01)
Mean Square Error3.10
R-Squared0.0002
Significance0.96
Slope(0)
Total Sum of Squares43.37

Cogent Receivables Turnover History

2025 7.06
2024 10.12
2019 11.25
2018 5.84
2017 10.07
2016 6.85

About Cogent Biosciences Financial Statements

Cogent Biosciences shareholders use historical fundamental indicators, such as Receivables Turnover, to determine how well the company is positioned to perform in the future. Although Cogent Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Cogent Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Cogent Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Receivables Turnover 10.12  7.06 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cogent Stock Analysis

When running Cogent Biosciences' price analysis, check to measure Cogent Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cogent Biosciences is operating at the current time. Most of Cogent Biosciences' value examination focuses on studying past and present price action to predict the probability of Cogent Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cogent Biosciences' price. Additionally, you may evaluate how the addition of Cogent Biosciences to your portfolios can decrease your overall portfolio volatility.